Miglustat therapy in juvenile Sandhoff disease.

Abstract excerpt

GM(2)-gangliosidosis is a rare and heterogeneous inherited metabolic disorder caused by autosomal recessive mutations in genes encoding the lysosomal enzyme β-hexosaminidase, resulting in the accumulation of ganglioside GM(2) in various tissues, particularly the central nervous system. It is characterized by progressive neurological deterioration that mainly affects motor and spinocerebellar function. Several...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 1-Deoxynojirimycin
• Share to Cerebellum
• Share to Child, Preschool